N C de Lanerolle - JoVE Visualize

Showing results (31-40 of 37) with videos related to

Pageof 4

Sort By:

You have reached the last page of results.This site can display upto 37 results.

Brain Research|July 24, 1995

Vasoactive intestinal polypeptide and its receptor changes in human temporal lobe epilepsyN C de Lanerolle, M Gunel, S Sundaresan, et al.

Magnetic Resonance in Medicine|July 27, 2007

Spectroscopic imaging of the pilocarpine model of human epilepsy suggests that early NAA reduction predicts epilepsyW A Gomes, F A Lado, N C de Lanerolle, et al.

Neurobiology of Disease|November 23, 2006

Changes in glial glutamate transporters in human epileptogenic hippocampus: inadequate explanation for high extracellular glutamate during seizuresL P Bjørnsen, T Eid, S Holmseth, et al.

Epilepsy Research|October 23, 1997

Dynorphin and the kappa 1 ligand [3H]U69,593 binding in the human epileptogenic hippocampusN C de Lanerolle, A Williamson, C Meredith, et al.

Proceedings of the National Academy of Sciences of the United States of America|September 14, 2000

Erythropoietin crosses the blood-brain barrier to protect against experimental brain injuryM L Brines, P Ghezzi, S Keenan, et al.

Neurology|April 1, 1992

"Central" and "peripheral" benzodiazepine receptors: opposite changes in human epileptogenic tissueE W Johnson, N C de Lanerolle, J H Kim, et al.

Lancet (London, England)|January 16, 2004

Loss of glutamine synthetase in the human epileptogenic hippocampus: possible mechanism for raised extracellular glutamate in mesial temporal lobe epilepsyT Eid, M J Thomas, D D Spencer, et al.

Pageof 4

Showing results (31-40 of 37) with videos related to

Sort By:

Pageof 4

You have reached the last page of results.This site can display upto 37 results.

Brain Research|July 24, 1995

Vasoactive intestinal polypeptide and its receptor changes in human temporal lobe epilepsyN C de Lanerolle, M Gunel, S Sundaresan, et al.

Magnetic Resonance in Medicine|July 27, 2007

Spectroscopic imaging of the pilocarpine model of human epilepsy suggests that early NAA reduction predicts epilepsyW A Gomes, F A Lado, N C de Lanerolle, et al.

Neurobiology of Disease|November 23, 2006

Changes in glial glutamate transporters in human epileptogenic hippocampus: inadequate explanation for high extracellular glutamate during seizuresL P Bjørnsen, T Eid, S Holmseth, et al.

Epilepsy Research|October 23, 1997

Dynorphin and the kappa 1 ligand [3H]U69,593 binding in the human epileptogenic hippocampusN C de Lanerolle, A Williamson, C Meredith, et al.

Proceedings of the National Academy of Sciences of the United States of America|September 14, 2000

Erythropoietin crosses the blood-brain barrier to protect against experimental brain injuryM L Brines, P Ghezzi, S Keenan, et al.

Neurology|April 1, 1992

"Central" and "peripheral" benzodiazepine receptors: opposite changes in human epileptogenic tissueE W Johnson, N C de Lanerolle, J H Kim, et al.

Lancet (London, England)|January 16, 2004

Loss of glutamine synthetase in the human epileptogenic hippocampus: possible mechanism for raised extracellular glutamate in mesial temporal lobe epilepsyT Eid, M J Thomas, D D Spencer, et al.

Pageof 4